Palisade Bio, Inc. - Common Stock (NQ:PALI)

1.480 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Palisade Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Palisade Bio Advances PALI-2108 Into Phase II for Ulcerative Colitis and Crohn’s ↗

September 27, 2026

Palisade Bio (NASDAQ:PALI) said it is advancing its lead drug candidate, PALI-2108, into Phase II studies for ulcerative colitis and Crohn’s disease after completing its Phase I program. Chief...

Via MarketBeat

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline ↗

May 21, 2026

Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric conditions in a pre-clinical model.

Via The Motley Fool

Topics Intellectual Property Regulatory Compliance

Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year ↗

May 21, 2026

ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.

Via The Motley Fool

Topics Economy Regulatory Compliance

Palisade Bio Stock Climbs To 9-Month High After $120M Stock Offering; Retail Sees More Gains Ahead ↗

October 02, 2025

Via Stocktwits

What's going on in today's after hours session ↗

April 20, 2026

Via Chartmill

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges ↗

March 22, 2026

Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.

Via The Motley Fool

Traders are paying attention to the gapping stocks in Monday's session. ↗

December 29, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

What's going on in today's after hours session ↗

October 08, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Unusual volume stocks are being observed in Wednesday's session. ↗

October 08, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut ↗

October 08, 2025

Steven Cohen's Point72 Asset Management has doubled the S&P 500's three-year return and is investing in this biotech firm...

Via Benzinga

Topics Stocks

Which stocks have an unusual volume on Monday? ↗

October 06, 2025

Volume analysis on 2025-10-06: stocks with an unusual volume in today's session.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

October 06, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket ↗

October 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 06, 2025

Via Benzinga

Unusual volume stocks are being observed in Friday's session. ↗

October 03, 2025

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 02, 2025

Via Benzinga

Unusual volume stocks are being observed in Thursday's session. ↗

October 02, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Which stocks are moving before the opening bell on Thursday? ↗

October 02, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

Which stocks are moving on Wednesday? ↗

October 01, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Power Metallic (TSXV: PNPN | OTCQB: PNPNF) Eyes NYSE Uplisting as Polymetallic Discoveries Accelerate – More Stocks Inside

October 01, 2025

Via AB Newswire

Discover the most active stocks in Wednesday's session. ↗

October 01, 2025

Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 01, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

October 01, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

October 01, 2025

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 11, 2025

Via Benzinga

Curious about the most active stocks on Thursday? ↗

August 07, 2025

Get a pulse on the US markets on Thursday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Via Chartmill

Loop Industries (NASDAQ: LOOP) Builds Global Momentum in Circular Textiles w/ Twist™ – More Stocks Inside

August 07, 2025

Via AB Newswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.